Wang X, Aukland K, Iversen B M
Medical Department A, Haukeland Hospital, Bergen, Norway.
J Cardiovasc Pharmacol. 1996 Dec;28(6):833-41. doi: 10.1097/00005344-199612000-00014.
The effects of angiotensin II type 1 receptor antagonist (losartan), angiotensin 1-converting enzyme (ACE) inhibitor (enalapril), and calcium channel blocker (nifedipine) on autoregulation of total and zonal glomerular filtration rate (GFR) were studied in spontaneously hypertensive rats (SHRs), 10 and 40 weeks of age, and 10-week-old Wistar-Kyoto (WKY) rats. Untreated animals in each group served as controls. Renal blood flow (RBF) was measured by a transit-time flow probe (Transonic) on the left renal artery. Total and zonal GFR (outer, middle, and inner cortex) were estimated from tubular uptake of 125iodine-labeled aprotinin (125IAp) injected i.v. at control renal arterial pressure (RAP), and 131IAp injected at a RAP reduced to the lower limit of RBF autoregulation. Autoregulation of RBF was reset to higher pressure levels in untreated hypertensive rats. Enalapril normalized this resetting in 10-week-old SHRs, but not in aged SHRs 40 weeks. Losartan did not completely normalize this resetting in either 10-or 40-week-old SHRs, whereas nifedipine impaired RBF autoregulation in both WKYs and SHRs. A decreased autoregulatory compensation of GFR after pressure reduction was observed in losartan-treated 10-week-old SHRs and after all drug regimens in 40-week SHRs. GFR autoregulation in outer, middle, and inner cortex was impaired in losartan-treated 10-and 40-week-old SHRs. With all treatments, the autoregulation in 10- and 40-week-old SHRs was better preserved in the inner than in the outer cortex. The impaired autoregulation may indicate that a part of the dilatory capacity of preglomerular vessels has already been taken out by hypotensive treatment. Renal vascular abnormalities may have an additional effect.
研究了1型血管紧张素II受体拮抗剂(氯沙坦)、血管紧张素1转换酶(ACE)抑制剂(依那普利)和钙通道阻滞剂(硝苯地平)对10周龄和40周龄自发性高血压大鼠(SHR)以及10周龄Wistar-Kyoto(WKY)大鼠的总肾小球滤过率(GFR)和分区肾小球滤过率自动调节的影响。每组未治疗的动物作为对照。通过左肾动脉上的渡越时间血流探头(Transonic)测量肾血流量(RBF)。在对照肾动脉压(RAP)下静脉注射125碘标记的抑肽酶(125IAp),以及在RAP降至RBF自动调节下限后注射131IAp,以此估算总GFR和分区GFR(外皮质、中皮质和内皮质)。未治疗的高血压大鼠的RBF自动调节被重置为更高的压力水平。依那普利使10周龄SHR的这种重置恢复正常,但40周龄的老年SHR则未恢复正常。氯沙坦在10周龄或40周龄的SHR中均未完全使这种重置恢复正常,而硝苯地平在WKY大鼠和SHR中均损害了RBF自动调节。在氯沙坦治疗的10周龄SHR中以及在40周龄SHR的所有药物治疗方案后,观察到压力降低后GFR的自动调节补偿降低。氯沙坦治疗的10周龄和40周龄SHR中外皮质、中皮质和内皮质的GFR自动调节均受损。在所有治疗中,10周龄和40周龄SHR的内皮质自动调节比外皮质保存得更好。自动调节受损可能表明肾小球前血管的部分扩张能力已被降压治疗所消除。肾血管异常可能有额外影响。